What is it about?

Extracellular vesicles (EV)s are emerging as novel, potential markers and mediators of type 2 diabetes (T2D) complications. We showed that CD31+EVs shuttle a miRNA signature associated with the presence of cardiovascular complications in patients with T2D and also that are able to promote an inflammatory phenotype in endothelial cells.

Featured Image

Read the Original

This page is a summary of: CD31+ Extracellular Vesicles From Patients With Type 2 Diabetes Shuttle a miRNA Signature Associated With Cardiovascular Complications, Diabetes, October 2020, American Diabetes Association,
DOI: 10.2337/db20-0199.
You can read the full text:

Read

Contributors

Be the first to contribute to this page